# Radiation Therapy and Hormone Therapy in Treating Patients With Prostate Cancer

> **NCT00769548** · PHASE3 · COMPLETED · sponsor: **Radiation Therapy Oncology Group** · enrollment: 1322 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** flutamide
- **DRUG:** goserelin acetate
- **RADIATION:** low-LET photon therapy

## Key facts

- **NCT ID:** NCT00769548
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-04
- **Primary completion:** 2001-04
- **Final completion:** 2016-12
- **Target enrollment:** 1322 (ACTUAL)
- **Last updated:** 2017-01-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00769548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00769548, "Radiation Therapy and Hormone Therapy in Treating Patients With Prostate Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00769548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*